A hearing on recreational marijuana comes next month
On April 23, 2026, the U.S. Justice Dept. and Drug Enforcement Administration (DEA) ordered state-licensed medical cannabis and FDA-approved marijuana products to be moved from Schedule I to a less-restricted Schedule III status (https://bit.ly/48hV9n0). This reclassification doesn’t legalize cannabis on the federal level, but it’s expected to have significant tax benefits for some cannabis businesses. […]
Read More A hearing on recreational marijuana comes next month